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Stress electrocardiography (sECG) or treadmill stress testing is a well validated noninvasive diagnostic
modality available to clinicians at low cost yet providing valuable functional data for coronary artery
disease (CAD) diagnostic and prognostic evaluation. With the advances in cardiac imaging in both
functional and anatomic fronts and the existing limitations of sECG testing, this modality appears less
favored worldwide as reﬂected in some recent guideline updates. We review the past present and future
of sECG to provide a viewpoint on where it stands in CAD evaluation and if it will remain relevant as a
diagnostic modality or be retired going forward. We also provide our perspectives on how sECG can coexist with other modalities such as calcium scoring and discuss the role of such testing in the Indian
population.
© 2022 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction and historical perspective
Fiel and Seigel in 1928 are probably credited with the ﬁrst
description of ST and T wave changes on electrocardiography (ECG)
in patients during chest pain subjected to repeated sitting and
standing with demonstration of subsequent regression of these
changes with cessation of exercise or administration of nitroglycerin1 Subsequent multiple other publications including that of
Misaal2 and Masters et al3 documented the same phenomenon
ushering in the era of stress electrocardiography (sECG). The
introduction of the Bruce protocol in 19564 established the methodologies of stress protocols upon which many subsequent modiﬁcations of stress testing protocols emerged. In the 1970s, the
concept of Bayesian analysis to evaluate pre-test likelihood of coronary artery disease (CAD) to help guide choice of appropriate
patients for noninvasive testing was introduced and adopted
widely in guidelines for stress testing.5 The 1980s saw the evolution
of sECG testing to incorporate imaging with radionuclide
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myocardial perfusion imaging ie single-photon emission computerized tomography (SPECT]) to increase sensitivity of detection of
CAD, albeit with radiation exposure6 followed by sECG with echocardiography in the 1990s which continues to be widely adopted to
the present day.
For the purposes of this review we will divide the era of sECG
into past (1970e2005), present (2005e2020) and future (2021 and
beyond) to highlight the changing landscape of assessment and
prognosis of CAD and if sECG will continue to withstand the
competition from advanced CAD imaging or sing its “swan song.”
2. The past
Diagnostic and prognostic testing of CAD with sECG has been
widely established and often used as the ﬁrst step in evaluation of
chest pain. sECG has also been used extensively to assess functional
capacity, evaluate for arrhythmias, monitor effects of medical
therapy and provide exercise prescription for those wanting to
engage in physical activity. It has established itself since its inception as an inexpensive, widely available, safe and easy to perform
initial test for many decades. The 2002 American College of Cardiology updated guidelines on sECG and the 2005 American Heart
Association guidelines for testing in women both recommended
sECG as ﬁrst line for evaluation of suspected CAD in intermediate
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related parameters such as heart rate reserve (peak e rest heart
rate) and chronotropic index (heart rate reserve/metabolic reserve)
have all been shown to have prognostic implications.23e25 In
particular a chronotropic index of <0.80 (normal being 1) is associated with adverse long-term outcomes.25

pre-test likelihood patients with normal or near normal resting
ECG.7,8 The diagnostic value of sECG for CAD detection using
standard ST-segment depression criteria (1-mm horizontal
depression at 60e80 ms from J point9) has enjoyed variable success
in men and women. In a meta-analysis of mostly male subjects,
sensitivity was reported as 81% and speciﬁcity 66%.10 However,
sensitivity as low as 45% and speciﬁcity around 85% have also been
reported when “work up or referral bias” was accounted for. The
diagnostic value of ST depression in women is much less than men
with sensitivity of 61% and speciﬁcity 70%11 and in another study,
positive predictive value of ischemic ST depression compared to
coronary angiography was much lower compared to men (47% vs
77%, p < 0.05)12 Although the exact reasons for this lower predictive value or higher “false positive” rate in women is unclear, some
factors attributed to this phenomenon include greater baseline ST
changes in women, estrogen based digoxin like ST-segment effect
and timing of testing related to menstrual cycle.
Prognostically, ST-segment depression and exercise capacity has
been the cornerstone for predicting outcomes for many decades. In
a predominantly male database from the Duke Cardiovascular Data
Bank, the presence of 1-mm ST depression within the ﬁrst 2 stages
of Bruce protocol was associated with worse outcomes.13 On the
contrary those achieving 10 metabolic equivalents or more on the
Bruce protocol had a low risk of cardiac events regardless of presence or absence of ST depression.14 The prognostic value of ST
depression in symptomatic women was evaluated in the What Is
the Optimal Method of Ischemia Evaluation in Women Trial
(WOMEN), which compared sECG to sECG þ SPECT and showed no
differences in outcomes.15 Furthermore ST depression had no
prognostic value in asymptomatic women in another study.16 The
ability to exercise at least 2 stages of the Bruce protocol and achieve
6 metabolic equivalents has been shown to be associated with
lower risk of cardiovascular events. In a study of CAD diagnosis
using sECG and SPECT, those who achieved 10 metabolic equivalents or more had a 0% prevalence of signiﬁcant ischemia on
SPECT.17 One of the widely used parameters in sECG prognosis is
the Duke treadmill score (DTS), which factors in exercise time,
maximum ST depression and presence of angina during test. Those
with a DTS of 5 or above had excellent 5-year prognosis whereas
those with a DTS worse than 11 had poor outcomes.18 The complementary role of SPECT with DTS has been shown with ist ability
to further risk stratify patients with intermediate DTS into lower or
higher risk based on presence or absence of ischemia.19
Too often clinicians focus only on ischemia criteria and look for
“yes” or “no” answer in a sECG study. Many other important parameters are available in sECG study but unfortunately are not
widely appreciated or weighted as part of study interpretation.
These include blood pressure and heart rate response, heart rate
recovery and presence of exercise induced arrhythmias all of which
add value to the sECG mainly from prognostic standpoint. The
ability to augment systolic blood pressure during sECG has been
shown to be inversely correlated to angiographic CAD. An exaggerated or hypertensive response (systolic blood pressure >210 mm
Hg and >190 mm Hg in women) in young adults was shown to be a
future predictor for hypertension20 whereas a fall in systolic blood
pressure (10 mm Hg) or delayed recovery of blood pressure in
recovery phase was associated with left main or severe CAD.21
Chronotropic response is key to adequate diagnostic accuracy of
sECG and an integral part of sECG prognostic value. In general
achieving 85% predicted maximum heart rate (220 - age x 0.85)
has been used as adequate chronotropic response. However, the
predicted maximal heart rate for women has been redeﬁned as
206e0.88 x age based on the St. James Women Take Heart study.22
Chronotropic incompetence or inability to achieve adequate heart
rate has been associated with adverse long-term outcomes and

3. Present
Although sECG is recommended as an initial test for evaluation
of patients with chest pain and intermediate likelihood of CAD,26,27
it is less and less used as a stand-alone test in the United States
currently. This is likely due to multiple reasons some of which have
been alluded to earlier: limited sensitivity and speciﬁcity, false
positives and the ready availability of more sensitive imaging modalities for detection and localization of ischemia such as SPECT,
stress echocardiography(SE) and most recently over the last 15
years, coronary computed tomography (CCTA). Perfusion abnormalities, diastolic dysfunction and wall motion abnormalities all
precede sECG changes in the ischemic cascade. As we use various
stress imaging modalities and hence identify these earlier imaging
signs of ischemia, the sensitivity of detecting true subendocardial
ischemia with SE) or ﬂow heterogeneity (SPECT or PET) increases
albeit with some loss of speciﬁcity particularly when dealing with
perfusion imaging. As ruling out signiﬁcant CAD is the primary aim
for ischemia based testing, the paradigm has shifted accordingly to
incorporating SPECT or echocardiography with sECG to enhance
sensitivity and to localize ischemia better. This combination of sECG
and imaging provides the clinician a wealth of information to better
risk stratifying individuals into low, intermediate, and high risk
categories. There is substantial accumulated evidence that SPECT
perfusion can reclassify patients in low, intermediate, and high risk
sECG categories as determined by the DTS.19 Although prior studies
from our group using sECG echocardiography have suggested that
patients with sECG changes suggestive of ischemia and normal
stress echocardiogram have long-term favorable outcomes,28 more
recent studies have suggested that these patients may still be at
slightly higher risk. Hence to some extent this study appears to
reemphasize the prognostic value of sECG changes in absence of
imaging evidence for ischemia.29 It is possible that abnormal sECG
maybe more reﬂective of endothelial dysfunction rather than
obstructive CAD in this discordant setting, in contrast to echocardiography, which is a better marker of obstructive CAD as it primarily evaluates wall motion abnormalities related to ischemia.30
Speciﬁc indications do still exist where sECG alone is used
outside of CAD evaluation such as assessing exercise capacity and
exercise hemodynamics in asymptomatic valvular heart disease,
evaluation of palpitations, for exercise induced arrhythmias and
pre-cardiac rehabilitation or exercise program assessment for exercise prescription. Speciﬁcally, sECG continues to be recommended in 2020 American College of Cardiology/American Heart
Association valvular heart disease guidelines speciﬁcally in
asymptomatic aortic stenosis assessment and in combination with
echocardiography for assessment of mitral valve stenosis and
regurgitation for clariﬁcation of hemodynamic response and
impact of valve disease on exercise parameters along with symptom correlation.31
sECG has also been part of major clinical trials evaluating
ischemia. As discussed earlier, the WOMEN trial randomized
symptomatic women to sECG versus SPECT and showed no differences in outcomes at 2 years along with higher cost and exposure to
radiation with use of SPECT. This trial questioned the common
notion among physicians that sECG may not be ideal as an initial
diagnostic test in women due to higher false positive response.
Furthermore, with no radiation and a high negative predictive
value, it serves as a safe low cost option to assess symptomatic
2
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women particularly in the low-intermediate risk category.15 In a
retrospective registry comparing the complementary value of sECG
and CCTA, 582 patients underwent both tests. This study showed
that in patients with low to intermediate risk sECG based on DTS,
despite the presence of non-obstructive atherosclerosis on CCTA,
sECG retained its prognostic value whereas in higher risk sECG (DTS
<5), CCTA provided the most prognostic information. Similarly,
sECG was also used as part of PROMISE trial, which evaluated
functional testing (10% of randomized patients to functional testing
had sECG) versus CCTA and showed no difference between these
two strategies in initial approach to evaluation of suspected coronary disease.32 In a more recent trial of 9849 patients with chest
pain (SCOT-HEART trial), of whom 4146 were ultimately randomized, 85% of patients underwent sECG and then were randomized to
CCTA versus standard of care.33 In this trial, CCTA increased the
frequency of cardiac catheterizations but did clarify initial diagnosis
of angina as CAD or not more often than sECG. After 1.7 years of
follow-up, CCTA was associated with a lower incidence of
myocardial infarctions. There was no difference in revascularization
between both groups. This trial set the stage for a contemporary
direct comparison between a single common test, such as sECG
versus sECG þ CTCA, as a new paradigm and clearly showed that
addition of an anatomic to a functional study increases implementation of preventive therapies, such as statins and antianginal
therapies, compared to standard of care. This most likely is related
to a more correct diagnosis of CAD in the CCTA group. The decrease
in myocardial infarction was likely driven by preventative therapy
instituted as part of atherosclerosis diagnosis by CCTA. These
ﬁndings has now been again conﬁrmed in the ﬁve year extension
data of SCOT-HEART.

The Achilles heel for sECG remains its low-average sensitivity
and speciﬁcity along with lack of localization and extent of
ischemia. This has served as the major driver for its declining
popularity compared to other stress imaging modalities. Stress
imaging on the other hand despite combining exercise in some of
its protocols still can evaluate for only moderate-severe CAD in
most cases as the crux of all stress tests is to evaluate coronary ﬂow
reserve limitations which remains intact in mild-moderate CAD.
Hence a substantial portion of early atherosclerosis (mild-moderate
non-obstructive plaque) remains undetected, as ECG response,
perfusion and wall motion are usually preserved in early CAD. This
scenario represents a missed opportunity not only for early
detection of atherosclerosis but also for non-initiation of preventive
lifestyle strategies and statin therapy initiation. Thus, techniques
like coronary calcium score and CCTA whose strength lies in
detection of any degree of atherosclerosis have been able to ﬁll this
gap by detection of atherosclerosis spanning the entire spectrum of
non-obstructive to obstructive CAD. This was illustrated in the
SCOT-HEART trial which showed that CCTA strategy impacted
outcomes with reduction in MI likely from more implementation of
preventive strategies like statins once any atherosclerosis is
detected. The much awaited 2021 ACC/AHA chest pain guidelines37
has now acknowledged the growing diagnostic and prognostic
value of atherosclerosis detection by given CCTA a Class 1 (level A)
recommendation with adjunct use of fractional ﬂow reserve by CT
(FFRCT) as an initial test of choice in patients presenting with chest
pain and suspected CAD. This in a way provides a combination of
atherosclerotic plaque delineation and when indicated a functional
assessment of detected disease with FFRCT or even better with
sECG which can provide a wealth of functional information. An
important limitation of CCTA ± FFRCT is that it can only evaluate
epicardial CAD. The spectrum of CAD as we now understand spans
into the micro-circulation with many patients having angina or
ischemia without obstructive CAD (ANOCA or INOCA). These can
only be evaluated by functional testing and not simulated hyperemia using FFRCT. Keeping cost and radiation exposure in mind
when we do multiple tests, one could envision using routine calcium scoring for detection of atherosclerosis and treadmill testing
for ischemia assessment as a simple yet effective initial strategy for
workup of chest pain and suspected CAD. This concept is not
entirely new and was proposed almost 8 years ago as a low risk
option of combining anatomic and functional information for
diagnosis and prognosis of CAD.38 Although calcium score is well
established to prognosticate in asymptomatic atherosclerosis, its
role in predicting inducible ischemia has also been studied. Many
studies have shown that the incidence of ischemia on functional
studies (mainly SPECT) increase with increasing burden of calcium.39,40 These data have led to appropriate use criteria for SPECT
imaging to incorporate recommendations for selective use of SPECT
in patients with calcium score 400 as most studies show
increasing likelihood of ischemia at or beyond this level of calcium
score.41 On the other hand, calcium score <100 is associated with
very low inducible ischemia and could be used as a gatekeeper to
avoid further testing. Thus, calcium score with a functional study
such as sECG (referred to as ‘calcium treadmill test’) provides
atherosclerosis information plus key physiologic data points,
namely functional capacity, arrhythmia detection, hemodynamic
response to exercise and electrocardiographic ischemia. A
completely normal calcium treadmill test can help reassure both
patient and clinician of low cardiovascular risk warranting only
lifestyle and preventative medical therapy. An abnormal calcium
treadmill test will require further decision making regarding need
for further advanced imaging (CCTA or stress imaging) versus cardiac catheterization based on patient symptoms and extent of abnormalities. This step wise approach can be more easily

4. Future
4.1. Is treadmill testing ready for its swan song or can we resurrect
its role in CAD ?
Given the explosion of various imaging modalities, both functional and anatomic for noninvasive imaging of CAD, the sECG test
has come under intense scrutiny given its limited sensitivity and
speciﬁcity. The United Kingdom National Institute of Clinical
Excellence (NICE) 2010 recommendations deemphasized sECG
testing given its limited incremental prognostic value over clinical
assessment,34 and in its most recent update of 2010 recommendations in 2016, NICE recommended CCTA as ﬁrst-line testing for
chest pain and removed traditional Bayesian based pre-test likelihood assessment strategy arguing its inaccuracy and overestimation of CAD likelihood.35 This represented a major shift in
approach to suspected chest pain and diagnostic workup for CAD in
the United Kingdom. The European Society of Cardiology on the
other hand continues to recommend pre-test likelihood assessment but no longer recommends using sECG as a test to assess CAD,
quoting low sensitivity. In contrast the American College of Cardiology and American Heart Association continue to recommend
sECG in intermediate pre-test likelihood and ability to exercise.36 In
the most recent 2021 ACC/AHA chest pain guidelines, pre-test
likelihood estimates are still recommended and in intermediate
risk chest pain patients with no prior CAD, sECG still receives a Class
1 indication along with all other stress imaging modalities for
evaluation.37 This highlights that the divide in medical opinion on
value of sECG still very much exists amongst major societal recommendations. So, how do we reconcile with these conﬂicting
recommendations? Has the time really come for the sECG test to
sing its swan song or should it evolve to be part of CAD diagnostic
testing ?
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implemented rather than routinely performing SPECT/PET or CCTA,
which is costlier and/or expose patients to higher radiation burden.
The radiation from calcium score scan is minimal, mostly less than
2 milliseiverts, which is an acceptable tradeoff for the wealth of
diagnostic and prognostic information for the patient. Also as
recent studies such as ISCHEMIA42 have not shown a clear beneﬁt
of routinely intervening even with moderate-severe ischemia, one
could just adopt a trial of aggressive medical therapy even when
calcium treadmill test is abnormal if patient is asymptomatic or
minimally symptomatic.

hemodynamics for valvular disease assessment. However in the
current era, its use continues to decline given various advances in
imaging as outlined above. An ideal strategy would be to consider
the hybrid strategy of ‘calcium treadmill test’ to serve as gatekeeper
for diagnosis and prognosis of CAD. This could be a cost effective
initial approach to suspected CAD diagnostic evaluation particularly in India. sECG in our opinion is alive and well and is not ready
for its “swan song.”

5. The backdrop of cardiovascular disease in India and our
perspective for the adoption of “calcium treadmill test “in
India
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The enormous increase in cardiovascular disease burden (CVD)
in India is now well recognized and it is the leading cause of
mortality. In 2016 the estimated prevalence of CVD in India was
54.5 million.43 One in 4 deaths in India are due to CVD with CAD
and stroke contributing >80%. To fuel this CVD problem is the fact
that India has unfortunately gained the distinction of being dubbed
“diabetes capital of the world” with a projected estimate of 79.4
million people expected to have diabetes by 2030. Diabetes affects
macro and microcirculation and being the leading cause of CAD,
sets the stage of diffuse atherosclerosis which spans epicardial arteries to microcirculation. Although data regarding national utilization of various stress testing modalities in India is lacking, sECG
remains probably the most widely used test given its advantages of
being readily available, affordable cost and low risk. Thus its
applicability to the Indian population many of whom do not have
insurance coverage is attractive for hospitals and cardiology practices. At the same time most private and government hospitals in
India likely now have access to a reasonably state of art CT scanner
being used for multiple purposes. Thus incorporation of calcium
scoring program could be easily implemented for risk assessment.
Hence ‘calcium treadmill test” can then be thus instituted and requires minimum upfront costs to set up in Indian hospitals given
readily available resources. The approach to patient selection could
be on 2 fronts: 1) asymptomatic risk assessment (starting with
calcium score and risks stratifying as discussed before with sECG as
needed) versus 2) symptomatic assessment (starting with sECG and
adding further risk assessment with calcium score which may be
helpful to adjudicate borderline or mildly abnormal sECG).
For the majority of Indians who pay out of pocket for medical
costs, the “calcium treadmill test” will deﬁnitely be more palatable
than a costly CCTA or stress imaging test. Furthermore, a widespread adoption of this strategy will set the stage for earlier institution of preventative therapies like statins, low dose aspirin,
lifestyle counselling inclusion smoking cessation, exercise and
weight loss. Patients are more convinced for the need for risk
reduction when they see coronary calciﬁcation and its implications
rather than a stress test alone so the “combo” may be even more
powerful for medical advice. We would like to highlight that
starting with a calcium score could also prevents asymptomatic
patients from routinely undergo CCTA or stress testing which
unecessarily creates a cascade of additional tests for ﬁndings which
may or may not be clinically signiﬁcant.
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